Showing results (61-70 of 170) with videos related to
Sort By:
Pageof 17
Current Pharmaceutical Design|October 8, 2003
Radiogenetic therapy: strategies to overcome tumor resistanceB Marples, O Greco, M C Joiner, et al.Radiation Research|April 1, 1994
Multiphasic survival curves for cells of human tumor cell lines: induced repair or hypersensitive subpopulation?P Lambin, B Fertil, E P Malaise, et al.Radiation Research|February 1, 1991
Repopulation in murine skin after X-ray treatments with multiple fractions per dayR W Tsang, M C Joiner, A Rojas, et al.Medical Physics|December 17, 2010
"SABER": A new software tool for radiotherapy treatment plan evaluationBo Zhao, Michael C Joiner, Colin G Orton, et al.Journal of Cellular Physiology|October 21, 2003
How to overcome (and exploit) tumor hypoxia for targeted gene therapyOlga Greco, Brian Marples, Michael C Joiner, et al.European Journal of Cancer (Oxford, England : 1990)|January 23, 2002
Molecular approaches to chemo-radiotherapyB Marples, O Greco, M C Joiner, et al.Clinical Genitourinary Cancer|October 10, 2009
Dose escalation using a hypofractionated, intensity-modulated radiation therapy boost for localized prostate cancer: preliminary results addressing concerns of high or low alpha/beta ratioRavi Shridhar, Sue Bolton, Michael C Joiner, et al.The British Journal of Radiology|October 1, 1980
Misonidazole in fractionated radiotherapy: are many small fractions best?J Denekamp, N J McNally, J F Fowler, et al.Frontiers in Oncology|April 17, 2023
Proton versus photon radiation therapy: A clinical reviewZhe Chen, Michael M Dominello, Michael C Joiner, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 31, 2011
Dose escalation in prostate cancer using intensity modulated neutron radiotherapyMichael Snyder, Michael C Joiner, Andre Konski, et al.Pageof 17